Oscar Health, Inc. (NYSE:OSCR) Shares Purchased by Vanguard Group Inc.

Vanguard Group Inc. lifted its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 18.6% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 14,127,934 shares of the company's stock after buying an additional 2,211,743 shares during the quarter. Vanguard Group Inc. owned approximately 6.25% of Oscar Health worth $78,693,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Charles Schwab Investment Management Inc. lifted its stake in shares of Oscar Health by 19.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,125,355 shares of the company's stock valued at $6,268,000 after buying an additional 182,206 shares in the last quarter. Graham Capital Management L.P. bought a new stake in Oscar Health in the 3rd quarter valued at $894,000. Versor Investments LP bought a new stake in Oscar Health in the 3rd quarter valued at $553,000. Dark Forest Capital Management LP bought a new stake in Oscar Health in the 3rd quarter valued at $581,000. Finally, Algert Global LLC increased its holdings in Oscar Health by 160.1% in the 3rd quarter. Algert Global LLC now owns 147,567 shares of the company's stock valued at $822,000 after acquiring an additional 90,840 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Trading Up 3.0 %

Oscar Health stock traded up $0.42 during midday trading on Friday, reaching $14.40. The stock had a trading volume of 1,671,678 shares, compared to its average volume of 2,386,681. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.37. Oscar Health, Inc. has a 52-week low of $4.72 and a 52-week high of $18.55. The firm has a market cap of $3.31 billion, a price-to-earnings ratio of -12.00 and a beta of 1.79. The company has a fifty day moving average of $15.01 and a 200 day moving average of $10.22.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, topping analysts' consensus estimates of ($0.74) by $0.08. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period in the prior year, the company posted ($1.05) EPS. The firm's revenue for the quarter was up 43.9% on a year-over-year basis. On average, analysts anticipate that Oscar Health, Inc. will post -0.23 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on OSCR shares. The Goldman Sachs Group lifted their price target on shares of Oscar Health from $8.00 to $16.00 and gave the company a "neutral" rating in a report on Friday, February 9th. Wells Fargo & Company lifted their price target on shares of Oscar Health from $12.00 to $20.00 and gave the company an "overweight" rating in a report on Thursday, February 15th. TheStreet upgraded shares of Oscar Health from a "d" rating to a "c-" rating in a report on Wednesday, February 21st. Finally, Raymond James assumed coverage on shares of Oscar Health in a report on Friday, March 22nd. They issued an "outperform" rating and a $20.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $13.50.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.